Huadong Medicine Statistics

Total Valuation

Huadong Medicine has a market cap or net worth of CNY 58.14 billion. The enterprise value is 55.35 billion.

Market Cap	58.14B
Enterprise Value	55.35B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Huadong Medicine has 1.75 billion shares outstanding. The number of shares has increased by 0.15% in one year.

Shares Outstanding	1.75B
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.24%
Float	731.14M

Valuation Ratios

The trailing PE ratio is 18.78 and the forward PE ratio is 20.47. Huadong Medicine's PEG ratio is 1.36.

PE Ratio	18.78
Forward PE	20.47
PS Ratio	1.41
PB Ratio	2.68
P/FCF Ratio	23.11
PEG Ratio	1.36

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.27, with an EV/FCF ratio of 22.00.

EV / Earnings	17.85
EV / Sales	1.34
EV / EBITDA	12.27
EV / EBIT	15.09
EV / FCF	22.00

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.10.

Current Ratio	1.54
Quick Ratio	1.18
Debt / Equity	0.10
Debt / EBITDA	0.52
Debt / FCF	0.93
Interest Coverage	31.83

Financial Efficiency

Return on equity (ROE) is 14.58% and return on invested capital (ROIC) is 9.72%.

Return on Equity (ROE)	14.58%
Return on Assets (ROA)	6.63%
Return on Capital (ROIC)	9.72%
Revenue Per Employee	2.43M
Profits Per Employee	182,748
Employee Count	16,969
Asset Turnover	1.19
Inventory Turnover	6.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.98% in the last 52 weeks. The beta is 0.67, so Huadong Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-11.98%
50-Day Moving Average	29.57
200-Day Moving Average	31.80
Relative Strength Index (RSI)	61.98
Average Volume (20 Days)	13,112,972

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Huadong Medicine had revenue of CNY 41.20 billion and earned 3.10 billion in profits. Earnings per share was 1.77.

Revenue	41.20B
Gross Profit	13.55B
Operating Income	3.67B
Pretax Income	3.73B
Net Income	3.10B
EBITDA	4.41B
EBIT	3.67B
Earnings Per Share (EPS)	1.77

Full Income Statement

Balance Sheet

The company has 5.65 billion in cash and 2.34 billion in debt, giving a net cash position of 3.31 billion or 1.89 per share.

Cash & Cash Equivalents	5.65B
Total Debt	2.34B
Net Cash	3.31B
Net Cash Per Share	1.89
Equity (Book Value)	22.28B
Book Value Per Share	12.39
Working Capital	7.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.18 billion and capital expenditures -1.67 billion, giving a free cash flow of 2.52 billion.

Operating Cash Flow	4.18B
Capital Expenditures	-1.67B
Free Cash Flow	2.52B
FCF Per Share	1.44

Full Cash Flow Statement

Margins

Gross margin is 32.88%, with operating and profit margins of 8.90% and 7.53%.

Gross Margin	32.88%
Operating Margin	8.90%
Pretax Margin	9.05%
Profit Margin	7.53%
EBITDA Margin	10.70%
EBIT Margin	8.90%
FCF Margin	6.11%

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 2.04%.

Dividend Per Share	0.70
Dividend Yield	2.04%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	34.46%
Buyback Yield	-0.15%
Shareholder Yield	1.89%
Earnings Yield	5.33%
FCF Yield	4.33%

Dividend Details

Stock Splits

The last stock split was on June 21, 2019. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 21, 2019
Split Type	Forward
Split Ratio	1.2

Scores

Huadong Medicine has an Altman Z-Score of 5.18.

Altman Z-Score	5.18
Piotroski F-Score	n/a